Sodium Chloride Solution is a prescription medication solution for parenteral administration that helps to replenish fluids and electrolytes in your cat, dog or horse. It helps to rehydrate dehydrated pets and restores a proper electrolyte balance, helping them to feel better after a period of reduced fluid intake. It's also sometimes used to relieve the symptoms of pancreatic insufficiency disorder in dogs and cats.
Sodium chloride replaces depleted water, chloride, and sodium, and is an excellent choice for diluting antibiotics.
Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.
Tear overwrap down side at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process ma be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.
To add medication befor esolution administration
To add medication during solution administration
Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
The parenteral administration of Sodium Chloride Inhection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing ocngested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.
In patients with diminished renal function, administration of Sodium Chloride Inhection, USP may result in sodium retention.
Reactions which may occur because of the solution or the technique of adminsitration include febrile response, infection at the site of inhection, venous thrombosis or phlebitis extending from the site of inhection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Caution must be exercised in the administration of Sodium Chloride Injection, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear and seal is intact.
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overweap at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.